| Source: |
| Type: |
| RUBCN - Rubicon Autophagy Regulator Abbreviation: RUBCN, Rubicon Alternative Names: RUN Domain Beclin-1-Interacting and Cysteine-Rich Domain-Containing Protein Type: Autophagy regulator / Beclin 1-VPS34 complex regulator / noncanonical autophagy protein Function: Rubicon is a negative regulator of canonical autophagy that inhibits autophagosome maturation and autophagosome-lysosome fusion through interactions with the Beclin 1-VPS34-UVRAG machinery and related fusion components. In contrast, Rubicon is required for LC3-associated phagocytosis (LAP) and other noncanonical ATG8/LC3 conjugation pathways. Cancer: ↑ Rubicon expression is increased in several cancers and can promote tumor progression by suppressing canonical autophagic flux and by supporting Rubicon-dependent noncanonical pathways such as LAP that may reduce antitumor immune activity. High RUBCN expression has been associated with poor prognosis in some tumor types. Favorable Direction in Cancer: ↓ RUBCN may be favorable in cancers where Rubicon promotes tumor progression or immunosuppressive LAP. However, effects can depend on tumor type, immune context, and Rubicon isoform. Interpretation Note: Rubicon has opposite functional roles in different autophagy pathways: it inhibits canonical autophagy but is required for LC3-associated phagocytosis. Therefore, RUBCN ↑ should not automatically be interpreted simply as autophagy ↓ without identifying which pathway is being measured. |
| 8235- | LCA, | Anticancer effects of licochalcones: A review of the mechanisms |
| - | Review, | Var, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1786 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid